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W HEN President John F. Kennedy was inaugurated on a frigid afternoon in Jan-
uary 1961, whole organ transplantation was a 
fantasy for the ignorant and an impossibility for 
the informed. In the New England Journal of 
Medicine (January 5, 1961), the Nobel Laur-
eate, McFarland Burnet, had written: "Much 
thought has been given to ways by which tissues 
or organs not genetically and antigenically iden-
tical with the patient might be made to survive 
and function in the alien environment. On the 
whole, the present outlook is highly unfavorable 
to success .... " I 
On the day Kennedy died, November 22, 
1963, I was in an experimental laboratory at the 
Denver Veterans Administration Hospital carry-
ing out an orthotopic liver transplantation in a 
dog. In the 34 months of Kennedy's tenure, the 
feasibility of transplanting kidneys from other 
than twin donors had been established, and the 
prospects of extending this new technology to 
extrarenal organs including the liver and heart 
was explored. What had happened to raise these 
expectations? The reasons were straightforward. 
Progress already had been made or was soon to 
be made in the three major areas upon which 
organ transplantation depends. 
Most important was an explicit understanding 
of rejection and the possibility of controlling this 
process. The fact that rejection was an immuno-
logic phenomenon was established by Medawar 
during the Second World War.2 As a corollary, 
agents known to reduce immunologic responsive-
ness were predicted to mitigate rejection and this 
was proved to be the case with adrenal cortical 
steroids,3 total body irradiation,4,5 and 6-mercap-
topurine6.9 or its analogue, azathioprine. lo How-
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ever, the effects were relatively minor and of no 
practical consequence as yet for clinical applica-
tion. 1I 
In 1962 and 1963, combinations of these 
modalities were put together in therapeutic cock-
tails that allowed successful renal transplanta-
tion from other than twin relatives or even using 
nonrelated donors. 12-15 Furthermore, a state of 
host-graft nonreactivity was often achieved in 
such cases which allowed the eventual reduction 
of chronic immunosuppressive therapy.12 When 
this occurred, rehabilitation and return to a full 
life was achieved in kidney recipients on more 
than rare occasions. 16 The gold standard for 
many years was azathioprine-steroid therapy, 12.16 
to which heterologous antilymphocyte globulin 
(ALG) could be added. I? 
However, good results with renal transplanta-
tion could be obtained predictably only with 
transplantation between consanguineous donors 
and recipients. In 1979 and 1980, this picture 
which had remained unaltered for more than 15 
years was changed drastically with descriptions 
by Borel et al 18 of cyclosporine and the first 
clinical trials of this drug, used aloneJ9 or in 
combination with corticosteroids20 and eventu-
ally other agents. Even without cyclosporine, 
attempts had been made and sometimes success-
fully to transplant extrarenal organs including 
the liver/I-23 heart,24,25Iung,26 and pancreas/? but 
these were highly experimental and dangerous 
undertakings. With pharmacologic cocktails that 
contained cyclosporine, the picture changed. The 
majority of all kinds of cadaver organs could be 
expected to function chronically. 
At a somewhat slower pace, there were collat-
eral developments in organ preservation that 
allowed an extension of graft viability for long 
enough to permit movement of organs from city 
to city and the establishment of organ sharing 
networks. The techniques used involved two prin-
ciples. One was organ cooling with special infu-
sates whose constituents were cytoprotective. 
Recent developments have allowed the reliable 
preservation of human livers for more than a day 
with simple refrigeration28.29 and there is ample 
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reason to think that the same or slightly modified 
techniques will allow improved "slush" preserva-
tion of all of the organs. The alternative was 
continuous perfusion with blood or with a fluid 
that did not contain a blood component. 
Tissue matching is the third component of 
transplantation biology. Matching of antigens of 
the human histocompatibility complex located 
on chromosome 6 has proved to be impractical 
for cadaveric transplantation, largely because of 
the enormous complexity of the system. At a 
practical level, the most important application of 
tissue typing has been the "crossmatch" which 
attempts to identify with serologic techniques the 
presence of preformed antidonor antibodies in 
the recipient and to thereby avoid transplanta-
tion under such adverse circumstances. If pres-
ent, such antibodies can cause an immediate or at 
least greatly accelerated rejection of kidney, 
liver, and heart grafts by a process known as 
hyperacute rejection.30•32 
Developments in all three of the foregoing 
areas are not complete. The acquisition and 
application of further knowledge is certain to 
improve transplantation but by smaller incre-
ments. However, even now, what can be achieved 
is so substantial that transplantation has 
changed the basic philosophy of treatment of 
diseases of vital organ systems. Until recently, 
what could be done for diseases of specific vital 
organs was limited to dietary or drug manage-
ment designed to extract the last moment of 
function from a failing kidney, liver, heart, or 
lung. Along the way, surgical procedures were 
sometimes used which ultimately were ineffec-
tive and worse, often illogically conceived and 
actually harmful. 
When organ transplantation became a reality 
even in a limited sense, all of this was changed. 
Therapy including operations which jeopardized 
ultimate candidacy for organ replacement were 
reexamined. Surgical operations have been sup-
planted in many specific instances by the so-
called interventional procedures carried out by 
radiologists and internists. In hepatology centers, 
patients with end stage liver disease and bleeding 
esophogeal varices now have sclerotherapy per-
formed in preference to portal-systemic shunts, 
and those with intrahepatic bile duct strictures 
often undergo transhepatic procedures by radiol-
ogists instead of open operations which ruin the 
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portal hilum for later dissection. About 20 years 
ago, the specialty of nephrology underwent a 
similar revolution, and the same readjustment is 
now occurring in cardiology within the limits 
imposed by the organ supply. 
Fall-out dividends from transplantation have 
included a better understanding of the function 
and pathophysiology of different tissues and 
organs. Keener insight about the development of 
tumors and their potential regression under 
immune modulation has been made possible. 
However, the implications of transplantation 
have not been a matter solely for scientific and 
medical conferences. Adjustments have been 
made in the law to accommodate public need. 
Cottage industries concerned with transplanta-
tion have sprung up in ethics and in related 
philosophic fields. Discussions have covered such 
diverse subjects as new legislation, consider-
ations of cost-effectiveness, and the appropriate 
allocation of both material and intellectual 
resources of these endeavors. 
Radiologists have played a significant role at 
every step as the modern era of transplantation 
has developed. At the outset of this editorial, it 
was mentioned that one of the first forms of 
immunosuppression was with irradiation, and 
this therapeutic possibility has been kept alive by 
research with total lymphoid irradiation plus 
drug therapy and antigenic challenge for toler-
ance induction.33•34 
Diagnostic radiology has played such an 
important role that transplantation has become 
the most "radiology-intense" of all special-
ties. 35-37 The function and anatomic integrity of 
transplanted organs has been studied with the 
rapidly evolving radiologic techniques of the last 
quarter century, including radio nuclide scan-
ning, the diagnostic and therapeutic procedures 
of interventional radiology, and particularly in 
the last 10 years with the mass utilization of the 
imaging techniques. 
The suggestion that transplantation is the ful-
fillment of a dream imputes certain miraculous 
qualities to what has transpired. To see a patient 
who had been reduced by disease to a pitiful 
state, now restored to vibrant good health by 
transplantation of a kidney, liver, or heart does 
seem like a miracle. But, the way in which this 
happened can be explained easily by large and 
small developments in different disciplines, and 
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the deliberate application of these often unre-
lated advances into a coherent treatment plan. 
Radiologists have made their own contribution to 
this story and will continue to do so in the years 
ahead. 
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